Dr. Hibler is an expert in laser and cosmetic procedures, combining evidence-based medicine and cutting edge technologies to formulate personalized treatment plans for all his patients.

Following residency, Dr. Hibler completed a prestigious fellowship in laser and cosmetic dermatology at Harvard Medical School, Massachusetts General Hospital, and the Wellman Center for Photomedicine, one of the leading laser and cosmetics centers in the world. He is an expert in the use of injectable fillers (Restylane, Juvederm, Belotero, Radiesse), neuromodulators (Botox, Dysport, Xeomin, Jeuveau), and lasers in cosmetic dermatology. Additionally, he performs skin tightening treatments, including microneedling and radiofrequency treatments. His particular interests include laser rejuvenation, treatment of fine lines and wrinkles, scar treatment, disorders of pigmentation, and body contouring.

Prior to fellowship, he graduated from the Weill Cornell Dermatology Residency Program in New York City, where he received extensive training in medical, surgical, and cosmetic dermatology at New York-Presbyterian/Cornell, Memorial Sloan Kettering Cancer Center, Hospital for Special Surgeries, and NYC Health + Hospitals. As a strong believer in evidence-based medicine, he strives to apply the latest scientific findings and techniques to deliver the best possible care and results for each patient.

Dr. Hibler has extensive research experience, being awarded fellowships by Harvard Medical School and the Wellman Center for Photomedicine (Boston, MA), Memorial Sloan Kettering Cancer Center (New York City, NY), and the National Cancer Institute (Bethesda, MD). He has received over 20 awards for his academic achievement and research, including the prestigious Dr. Richard E. Fitzpatrick Clinical Research and Innovations Award from the American Society for Laser Medicine and Surgery. He has published over 50 peer-reviewed articles in leading journals on cosmetics, quality of life studies in dermatology, and using non-invasive imaging techniques to augment early diagnosis and management of complex skin cancers.